Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 17, 2025

A Case of Myelodysplastic Syndrome with Atypical Cytogenetics: A Case Report

View Full Paper
Ask AI
Bookmark
Share

Authors

SPSanka ParanavithanaSWSenani WilliamsMSMahendra Somathilaka

Discussion

Loading...

Member takes

Overview

Case report illustrates complex cytogenetics impacting treatment outcomes in myelodysplastic syndrome, suggesting improved evaluation may enhance prognosis.

Key Points

  • Identifying complex cytogenetic anomalies significantly impacts myelodysplastic syndrome prognosis and treatment.
  • The patient exhibited severe pancytopenia and dysplastic features, categorizing him as very high-risk disease.
  • Molecular analysis revealed atypical abnormalities involving multiple chromosomes, critical for tailored therapy.
  • Comprehensive cytogenetic evaluations are essential for precise prognosis in myelodysplastic syndrome cases.

Cite This Study

Paranavithana et al. (2025) studied this question.

synapsesocial.com/papers/68a36f8a0a429f79733325bfhttps://doi.org/10.21203/rs.3.rs-7299630/v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion2006 · 1,324 citations
  2. 2Molecular genetics in allogeneic blood stem cell transplantation for myelodysplastic syndromes2019 · 7 citations
  3. 3Revised International Prognostic Scoring System for Myelodysplastic Syndromes2012 · 3,196 citations
  4. 4The Genetics of Myelodysplastic Syndromes: Clinical Relevance2021 · 38 citations
  5. 5The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms2022 · 4,224 citations